Posted by: themossreports | December 5, 2010

INTRODUCING “CAM AND CANCER IN ISRAEL”


Doctors at Hadassah Hospital, Ein Kerem

This week I am happy to introduce a new special report on “CAM and Cancer in Israel.” This report is the result of a trip I took this summer to Israel, touring clinics and meeting doctors who use complementary and alternative medicine in this small but dynamic country. My visit took me to Tel Aviv, Haifa and Jerusalem and their environs. I visited doctors in private practice, in HMOs and in hospitals and university clinics. I also met with inventors and discoverers in this so-called “start up nation.” The trip was fascinating on many levels.  CAM is as popular in this small country as any place I have visited and its degree of integration into conventional medicine is arguably the greatest in the world! Although my focus is on what is offered to Israelis there are opportunities here for international cancer patients who want to explore integrative options from some of the finest doctors I know.

“CAM and Cancer in Israel” totals 63 pages in length. It includes photos of the main practitioners, as well as an appendix of contact information (addresses, phone numbers, emails) of these doctors. There is a ten-page bibliography of peer-reviewed journal articles on CAM in Israel and a listing of the major organizations that support CAM usage in this ancient land.

My visit was supported by a grant from a non-profit European foundation, Reliable Cancer Therapies. It was reviewed for accuracy by leading Israeli and American physicians. Some of their comments are given below:

“Ralph Moss’s report on CAM and cancer in Israel is extensive and enlightening. I thank him for his significant contribution and support of our activities in the Holy Land.”
—Eran Ben-Arye, MD, Haifa, Israel

“Ralph Moss’s report provides in-depth research on a subject never investigated before. In the course of his visit he reached most of the serious CAM-cancer practitioners in this country. He has shown that CAM can be practiced in a serious way and add greatly to the treatment of cancer patients.”
—Joseph Brenner, MD, Tel Aviv, Israel

“In this report, the story of CAM in Israel is told in a powerful, comprehensive and interesting way by a keen outside observer. I am impressed by Moss’s systematic and informative coverage, including relevant background information, a vast number of facts, and a balanced description of a large variety of CAM activities. Moss has done a great job.”
—Jacob Shoham, MD, PhD, Ramat-Gan, Israel

“Ralph Moss provides an in-depth report on CAM and cancer in Israel. His detailed encounter with the various experts is an important and much needed guide for both health providers and patients who are interested in this thriving field.”
—Isaac Eliaz, MD, Santa Rosa, Calif.

This new Moss report is now available for sale for $19.95 at our Web site, http://www.cancerdecisions.com. You can order it directly by clicking on the home page banner or by going directly to:
http://www.cancerdecisions.com/mrstore/index.php?main_page=product_info&products_id=639

Advertisements

Responses

  1. Of course there have been no clinical trials on phytochemicals or herbs for sarcoma. The following had the strongest evidencebase for sarcoma in my database of some 2,700 herbs. I list here just the more promising spices from a subset of 200 spice species in the bigger database.
    Allium cepa L. (Onion) (1; FNF)
    Allium chinense G. Don (Chinese Scallion) (1; FNF)
    Allium porrum L. (Leek) (1; FNF)
    Allium sativum L. (Garlic) (1; FNF; `HOS)
    Allium tricoccum Ait. (Ramp) (1; FNF)
    Allium tuberosum Rottl ex Spreng (Chinese Chives) (1; FNF; X17711341)
    Alpinia galanga (L.) Sw. (Greater Galangal) (1; `HOS)
    Armoracia rusticana Gaertn. et al. (Horseradish) (1; HOS; WO2)
    Calendula officinalis L. (Calendula) (f1; CRC, LIL)
    Curcuma longa L. (Turmeric) (1; `AGG; `HOS)
    Curcuma zedoaria (Christm.) Roscoe. (Zedoary) (1; `HOS)
    Ferula assa-foetida L. (Asafetida) (f; CRC; `HOS)
    Morinda citrifolia L. (Noni) (1; X14669249)
    Myristica fragrans Houtt. (Nutmeg) (1; FNF; HOS)
    Nasturtium officinale R. Brown (Watercress) (1; HH2)
    Orthosiphon aristatus (Blume) Miq. (Java Tea) (1; X11374950)
    Piper longum L. (Long Pepper) (1; X16751987)
    Punica granatum L. (Pomegranate) (1; X17157465)
    Sesamum indicum L. (Sesame) (1; X14528695)
    Sinapis alba L. ssp. alba (White Mustard) (f; JLH)

    Ironically I feel the evidence is best for pot marigold since it has scored f for folklore and 1 for in vivo, in vitro or phytochemicl or epidemeiological evidence. The score of 2 is reserved for clinical evidence or Comm E or TRAMIL evidence. There can be no clinical studies if herbs are not approved by the FDA for any cancer, as far as I know. Besides such studies cost 1.7 billion . Sincerely, Jim Duke


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: